Amy Rabourn
Treasurer at OCUPHIRE PHARMA, INC.
Net worth: 12 939 $ as of 2024-05-30
Amy Rabourn active positions
| Companies | Position | Start | End |
|---|---|---|---|
| OCUPHIRE PHARMA, INC. | Treasurer | - | - |
| Comptroller/Controller/Auditor | 2020-11-10 | - | |
| Director of Finance/CFO | 2019-11-30 | 2024-02-11 |
Career history of Amy Rabourn
Former positions of Amy Rabourn
| Companies | Position | Start | End |
|---|---|---|---|
| NEUROBO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2014-11-30 | 2019-11-30 |
Training of Amy Rabourn
| University of Michigan | Graduate Degree |
Statistics
International
| United States | 4 |
Operational
| Director of Finance/CFO | 2 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| OCUPHIRE PHARMA, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Gemphire Therapeutics, Inc.
 Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand. The company was founded by Charles L. Bisgaier and David Lowenschuss on October 30, 2014 and is headquartered in Livonia, MI. | Health Technology |
- Stock Market
- Insiders
- Amy Rabourn
- Experience
